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https://doi.org/10.1016/j.celrep.2018.11.029SUMMARY
The mammalian neocortex has undergone remark-
able changes through evolution. A consequence of
such rapid evolutionary events could be a trade-off
that has rendered the brain susceptible to certain
neurodevelopmental and neuropsychiatric condi-
tions. We analyzed the exomes of 65 patients with
the structural brain malformation periventricular
nodular heterotopia (PH). De novo coding variants
were observed in excess in genes defining a tran-
scriptomic signature of basal radial glia, a cell type
linked to brain evolution. In addition, we located
two variants in human isoforms of two genes that
have no ortholog in mice. Modulating the levels of
one of these isoforms for the gene PLEKHG6 demon-
strated its role in regulating neuroprogenitor differ-
entiation and neuronal migration via RhoA, with
phenotypic recapitulation of PH in human cerebral
organoids. This suggests that this PLEKHG6 isoform
is an example of a primate-specific genomic element
supporting brain development.
INTRODUCTION
Largely facilitated by changes in neural stem and progenitor cell
dynamics, themammalian neocortex has undergone remarkable
modifications in size, structure, and neuronal number through
evolution (Lui et al., 2011; Borrell and Reillo, 2012; BetizeauCell Repo
This is an open access article under the CC BY-Net al., 2013; Smart et al., 2002; Lewitus et al., 2014; Borrell and
Go¨tz, 2014; Sun andHevner, 2014; Picco et al., 2018). In the ven-
tricular zone (VZ), apical progenitors, collectively composed of
neuroepithelial cells and apical radial glia (aRG), divide to both
self-renew and generate neurons (via an intermediate cell popu-
lation) that migrate centrifugally to populate the cortical plate
(Rakic, 1988; Malatesta et al., 2000; Noctor et al., 2001, 2004;
Haubensak et al., 2004). Inmost primates and some non-primate
species, neurogenesis also initiates with aRG; however, these
cells can also divide to induce the production of another progen-
itor cell class called basal radial glia (bRG). Unlike their apical
counterparts, bRG cells lose their VZ attachments, delaminate
basally, and locate to an additional germinal layer, the outer sub-
ventricular zone (OSVZ) (Hansen et al., 2010; Fietz et al., 2010;
Reillo et al., 2011). Since a strong correlation exists between
regional cortical expansion and differences in abundance and
properties of neuroprogenitors across species, bRG cells are
proposed to constitute a major cellular substrate facilitating the
evolutionary expansion of the primate cerebral cortex (Hansen
et al., 2010; Fietz et al., 2010; Reillo et al., 2011). A consequence
of these rapid, expansive cortical evolutionary events, particu-
larly in humans, could be a trade-off that has rendered the brain
susceptible to certain neurodevelopmental and neuropsychiatric
conditions (Bae et al., 2014; Doan et al., 2016; Bershteyn et al.,
2017). Data from humans with such disorders could therefore
provide insight into recently evolved genetic substrates for cere-
bral cortical complexification.
Periventricular nodular heterotopia (PH) is a structural malfor-
mation of cortical development, characterized by a failure of
some neurons to locate correctly within the cerebral cortex;
instead, they adopt heterotopic positions close to their sites ofrts 25, 2729–2741, December 4, 2018 ª 2018 The Author(s). 2729
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1. Observed and Expected De Novo Variants Identified in
Patients with PH in Genes that Are Differentially Expressed in
aRG and bRG
Gene Set No. of Genes
PH (n = 65)
Exp Obs p
aRG 33 0.14 1 0.133
bRG 67 0.26 2 0.024*
Exact binomial test (two-tailed). Exp, expected; obs, observed. Asterisk
(*) indicates significant p value.production, themargins of the lateral ventricles (Guerrini and Do-
byns, 2014). PH has traditionally been viewed as a disorder of
abnormal migration, but recent data have outlined a role for
disorganized neural stem cell dynamics in its causation (Cap-
pello et al., 2013; Kielar et al., 2014). Mouse models often fail
to recapitulate human forms of PH, suggesting that species-spe-
cific differences, including evolutionarily dynamic mechanisms,
could underpin its pathogenesis (Feng et al., 2006; Hart et al.,
2006; Corbo et al., 2002; Johnson et al., 2018).
A recent study in which the coding region of the genome (the
exome) was sequenced in 202 individuals with PH, and their
unaffected parents demonstrated a substantial, albeit highly
heterogeneous, genetic component contributing to the etiology
of the condition (Heinzen et al., 2018). Such heterogeneity
makes the discovery of new loci and cellular processes under-
pinning its cause difficult. In this study, we sought to test the
hypothesis that variants in recently evolved exomic elements
contribute to the pathogenesis of PH. To investigate this, our
hypotheses were 2-fold. First, we hypothesized that genes
defining a differential expression signature for basal progenitors
(specifically bRG), but not their apical counterparts (aRG), are
enriched for genetic variants identified in individuals with PH.
Second, we proposed that rare variants in individuals with PH
would be found in human and/or primate exomic elements
that have no mouse ortholog, representing newly evolved
regions of the human and/or primate coding genome that
have properties that influence neurogenesis. Although the ge-
netic heterogeneity underlying PH would likely preclude such
loci fulfilling criteria for pathogenicity (Heinzen et al., 2018),
demonstration of their cellular functions could nevertheless
implicate them as newly evolved contributors to cortical
development.
To this end, we demonstrate here that de novo coding variants
identified in individuals with PH are located in genes associated
with bRG, but not aRG, function. Furthermore, genetic variants
identified in individuals with PH do occur in isoforms with no or-
tholog in mice. Although falling short of proof of pathogenicity on
genetic grounds, forced expression of one of these isoforms in
PLEKHG6 in the developing mouse cortex promoted defects in
cellular proliferation and neuronal migration via activating
RhoA, a gene whose knockout is associated with neuronal het-
erotopia (Cappello et al., 2012). Furthermore, modulating the
specific isoform of interest in PLEKHG6 phenotypically recapitu-
lates PH in human cerebral organoids. These results indicate a
role for bRG in PH etiology, demonstrate the utility of functional
assays in further investigating the relevance of candidate dis-
ease gene loci in genetically heterogeneous conditions, and2730 Cell Reports 25, 2729–2741, December 4, 2018highlight a primate-specific genomic element in the gene
PLEKHG6 in brain development.
RESULTS
EnhancedBurden ofDeNovoVariants in Individualswith
PH in Genes Associated with Basal Radial Glia Cell
Identity
To determine whether variants detected within the exomes of
individuals with PH localize to recently evolved genomic se-
quences, we independently aligned and variant called exomes
on a cohort of 65 proband-parent trios we recruited and identi-
fied 67 variants (50 de novo, 17 biallelic variants) not observed
within control datasets (Lek et al., 2016; Sherry et al., 2001; Au-
ton et al., 2015) (Tables S1 and S2). This cohort was a subfraction
of a larger collection of individuals with PH that were separately
analyzed on an independent platform as part of a study on the
genetic etiology of PH (Heinzen et al., 2018).
Given that primate brain complexification is linked to basal
radial glia (bRG) expansion, we questioned whether elevated
rates of variants were observed in genes that exhibit expression
signatures linked to bRG cell function. Transcriptional signatures
that can distinguish bRG from their apical counterparts (aRG)
have been defined (Pollen et al., 2015; Florio et al., 2015; Nowa-
kowski et al., 2017). Intersecting this gene set with loci with de
novo variants identified in our exome dataset yielded two genes
as common between the two groups, a significant excess
compared to the expectation on the basis of gene-specific rates
of variation (p = 0.024, exact binomial test; Table 1). In contrast,
when the same loci were intersected across the 33 aRG-associ-
ated genes (Pollen et al., 2015), only one, LRIG3, was shared in
common (p = 0.133, exact binomial test; Table 1). The distribu-
tion of non-synonymous de novo variants per patient also closely
approximated that expected by a Poisson distribution of random
mutational events, and all de novo events were confirmed by an
orthogonal technique. The rate of synonymous variants also did
not significantly deviate from the 0.27 events per exome ex-
pected (p = 0.527, exact binomial test). These data indicate
that the burden associations described here are not driven by
variant over-calling. Previous studies of populations with various
neurodevelopmental and neuropsychiatric disorders have also
observed an enrichment of identified de novo mutations in
various gene sets (Baye´s et al., 2011; Darnell et al., 2011; Feld-
man et al., 2008; Iossifov et al., 2012, 2014; Kang et al., 2011;
Voineagu et al., 2011). When compared to the genes with vari-
ants in this study, no enrichment of de novo events was observed
(Table S3), strengthening the specificity of our finding related to
bRG function.
Exomic Variants Detected in Individuals with PH within
Recently Evolved Regions of the Coding Genome
The observation that PH may result from mutations in genes
that have recently acquired adaptive functions in the brain
could be indicative of a more widespread phenomenon—that
PH etiology could be related closely to developmental vulnera-
bilities conferred by recently evolved genetic elements.
Although loci identified using this approach may fall short of
proof of pathogenicity on genetic grounds, such a hypothesis
Figure 1. Biallelic Knockout of a Primate-
Specific Isoform of PLEKHG6 in an Individ-
ual with PH
(A) University of California, Santa Cruz (UCSC)
Genome Browser tracks illustrating the PLEKHG6
locus and the deletion identified in a patient with
PH in an isoform that is present in humans, but not
mice. Top:the entire locus and all of the isoforms
annotated in mice and humans are outlined. Or-
ange box highlights the region shown at higher
resolution at bottom. Red arrow identifies the site
of the frameshift variant in PLEKHG6 isoform 4 for
which the index case is homozygous (Table S2).
100 Vert. track depicts multiple alignment data
for 100 vertebrate species and measurements
of evolutionary conservation (Rosenbloom et al.,
2015).
(B) Axial brain MRI scan of an individual homozy-
gous for the c.28delG variant in PLEKHG6 isoform
4. White arrowheads mark the presence of
bilateral, posterior-predominant, periventricular
nodular heterotopia.
(C) Sequence traces illustrating the sequence
variant c.28delG, present in a homozygous and
heterozygous state in the index case (bottom
trace) and parents (top two traces), respectively.
(D) Sequence homology observed at the tran-
scriptional start sites of isoforms 1 and 4 in the
indicated species.could inform the function of newly evolved regions of the hu-
man and/or primate coding genome and represent candidate
disease loci for further investigation, especially if associated
with cellular pathways already implicated in PH. To test this hy-
pothesis, we filtered for variants that are located within vali-
dated human transcripts (the Consensus Coding Sequence
[CCDS] [Pruitt et al., 2009]) that have no ortholog in mice. We
identified two variants in two different genes—one in ABAT
(de novo missense variant c.1426T>G [p.Ser476Ala]; RefSeq
NM_001127448) and PLEKHG6 (homozygosity for c.28delG
[p.Glu10Argfs*40]; RefSeq NM_001144857.1) (Figures 1A and
S1A). Since the variant identified in ABAT is missense and
therefore difficult to a priori assign functional significance to,
we focused on the loss-of-function genotype in PLEKHG6 (Fig-
ure 1C), a gene that encodes the guanine nucleotide exchange
factor (pleckstrin homology domain containing family G mem-
ber 6), as a potential novel locus regulating neurogenesis in hu-
mans. PLEKHG6 is an activator of the small Ras homologous
guanosine triphosphatase (RhoGTPase) RhoA (Asiedu et al.,
2009), the conditional depletion of which within the developing
mouse forebrain is associated with neuronal heterotopia (Cap-
pello et al., 2012).
The proband with the homozygous frameshift variant in
PLEKHG6 was diagnosed as having intellectual disability and
bilateral PH predominantly affecting the trigone, posterior, and
temporal horns of the lateral ventricles (Figure 1B; Table S4).
This patient also had no pathogenic variants identified in known
loci previously implicated in PH, including FLNA. Congruent with
studies that place PLEKHG6 beyond the 90th percentile for
genes exhibiting purifying selection (Huang et al., 2010; Petrov-ski et al., 2013), only two homozygous loss-of-function (LoF)
events are observed in PLEKHG6 in the Genome Aggregation
Database (gnomAD; representing 123,136 exome and 15,496
genome sequences from unrelated individuals) (Lek et al.,
2016). One of the individuals had the same genotype identified
in the present study, although their phenotypic status is un-
known. It is noteworthy that the individual in this study has
mild cognitive disability but no seizures, and therefore it is
possible that the individual listed in gnomAD may have a similar
or subclinical phenotype. Such instances have been docu-
mented for other loci implicated in the causation of PH (Heinzen
et al., 2018). These findings therefore represent a prima facie
case for this biallelic genotype associated with PH to be of func-
tional significance.
PLEKHG6 Isoforms Are Differentially Expressed in
Neural Progenitors and Neurons of Developing Human
Brains and Organoids
In humans, PLEKHG6 encodes at least five alternate transcripts
(Figure 1A), three of which have initiation codons within exon 2.
Isoforms 4 and 5, however, use unique first exons and conse-
quently encode proteins with novel N termini (Figures 1A and
1D). Transcriptional start sites directing the production of iso-
forms 4 and 5 are confined to primates (Figures 1D and S1B),
indicating that this regulatory innovation arose after the diver-
gence of primates from other mammalian species 65–85 million
years ago. The biallelic frameshift variant observed in the individ-
ual with PH lies in the exon 1-specifying transcript 4
(PLEKHG6_4) of human PLEKHG6 and predicts nullizygosity
for this isoform.Cell Reports 25, 2729–2741, December 4, 2018 2731
Figure 2. PLEKHG6_4 Knockdown in Hu-
man Cerebral Organoids Changes Cellular
Dynamics
(A and C) Micrograph sections of day 42 human
cerebral organoids electroporated with GFP-
empty vector control or human PLEKHG6 isoform
4 targeting miRNA (miPLEKHG6_4) and analyzed
7 dpe. Sections were then immunostained for
SOX2 (A) or MAP2 (C).
(B and D) Quantification of GFP-expression (GFP+)
cells transfected with GFP-empty vector alone or
miPLEKHG6_4 that also express (B) SOX2+ or (D)
MAP2 (means ± SEMs). Mann-Whitney U test;
*p < 0.05; **p < 0.01. n = 4–6 different organoids
per condition from two separate batches. Scale
bar represents 30 mm.Given that PLEKHG6 isoforms 1 and 4 (PLEKHG6_1 and _4,
respectively) differ only by their first coding exon and that no ho-
mology to known signal peptides was detected by Signal-BLAST
(Frank and Sippl, 2008) within the N termini encoded by these
unique exons, we hypothesized that differential expression is the
essential distinguishing feature between these two proteins. To
study this, we compared PLEKHG6_1 and PLEKHG6_4 expres-
sion in developing human cortices, specifically in apical and basal
radial glia andmigrating neurons at 12–13weekspost-conception
(pcw) (Florio et al., 2015). Consistent with differential expression
patterns distinguishing the two isoforms, these data recorded
PLEKHG6_1 as being expressed in migrating neurons and
PLEKHG6_4 in apical and basal radial glia cells (Figure S2B). An
overall greater trend for increased PLEKHG6 expression is also
observed in human radial glia compared tomice, further suggest-
ing an evolutionary link (Figure S2A) (Florio et al., 2015). Using vali-
dated polyclonal antibodies that recognize the unique N termini of
PLEKHG6_1 and PLEKHG6_4 (Figure S2C), we further assessed
for differential regulation of these two isoformsby immunostaining
human cerebral organoids. Consistent with the transcriptomic
data, PLEKHG6_1 is expressed in post-mitotic neurons (PCNA
MAP2+), while PLEKHG6_4 was present in both proliferating neu-
ral progenitors (PCNA+ MAP2) and neurons (Figures S2D and
S2E). To further assess the potential for differential expression
among the two isoforms, we analyzed histone signatures (histone
H3 lysine 4 tri- and monomethylation) and identified distinct pre-
sumptive promoters for PLEKHG6_1 and PLEKHG6_4 (Rose-
nbloom et al., 2013), which also correlatedwith enhancedDNaseI
hypersensitivity (Figure S3). Chromatin immunoprecipitation
sequencing (ChIP-seq) data (Rosenbloom et al., 2013) define a
mutually exclusive set of transcription factors that also locate
differentially at the two cis-regulatory elements for these isoforms
in non-overlapping cell types (Figure S3). These independent lines
of evidence support the differential regulation and expression of
PLEKHG6_1 and PLEKHG6_4.2732 Cell Reports 25, 2729–2741, December 4, 2018Modulation of PLEKHG6 Levels in
Cerebral Organoids Induces PH and
Is Non-cell Autonomous
PLEKHG6 activates the small GTPase
RhoA (Asiedu et al., 2009), a known
modulator of neuronal migration andcortical development in mice (Cappello et al., 2012). Conditional
depletion of RhoA within the developing mouse forebrain is
associated with cellular heterotopia; its knockdown in utero
increases the proportion of electroporated cells at more basal
positions along the cortical plate (Cappello et al., 2012). Such dif-
ferences in phenotype have been linked to the number of cells
disrupted using each strategy (Cappello et al., 2012). Thus, while
nullizygosity for the primate-specific isoform of PLEKHG6
(PLEKHG6_4) potentially contributes to the pathogenesis of PH
(and if the mechanism is mediated via RhoA), its knockdown
within developing organoid cultures would not induce heterotop-
ic cells lining the ventricle but instead increase the number of
electroporated cells at the cortical plate. Targeted PLEKHG6_4
knockdown in organoid cultures induced changes in the cellular
composition of GFP+ cells 7 days post-electroporation (dpe),
with an increased fraction of GFP+ cells that were also positive
for the neuronal marker MAP2 and decreased for the progenitor
marker SOX2 (Figures 2 and S4).
The primate-specific isoform of PLEKHG6 (PLEKHG6_4) is
lowly expressed in developing human cortical and cerebral or-
ganoid tissue (Camp et al., 2015; Florio et al., 2015). To further
explore PLEKHG6_4 in human brain development, we next
assessed the consequences of misregulation of PLEKHG6_4
expression by increasing its levels in organoids via electropo-
ration. Here, ectopic neurons (marked by NeuN) were identi-
fied at the ventricular surfaces of organoids at a higher
frequency after PLEKHG6_4 misregulation compared to con-
trols (Figures 3A and 3B). Notably, these ectopic NeuN+ cells
were GFP, indicating that their heterotopic positioning re-
sulted from a non-cell autonomous mechanism induced by
PLEKHG6_4 overexpression (Figures 3A and 3B). Associated
anomalies observed after electroporation of the PLEKHG6_4
construct also included progressive disruption of the neuroepi-
thelial lining and defective apical junction assembly (Figures
3C, 3D, and S5). Specifically, control organoids had a fine
Figure 3. PLEKHG6_4 Dysregulation in Human Cerebral Organoids Impairs Ventricular Surface Integrity and Induces PH Formation
Micrograph sections of day 42 human cerebral organoids electroporated with GFP-empty vector control or human PLEKHG6 isoform 4 (PLEKHG6_4) and
analyzed 4 or 7 dpe. Sections were then immunostained for NeuN, b-catenin, or SOX2, as indicated.
(A) White arrowheads indicate NeuN+GFP cells ectopically located directly adjacent to the ventricular surface within the electroporated zone.
(B) Quantification of the percentage of ventricles with ectopic NeuN+ cells transfected with GFP-empty vector control or human PLEKHG6_4 in (A).
(C) Red and yellow arrowheads indicate the b-catenin profile at the electroporated and adjacent non-electroporated ventricular surfaces, respectively.
(D) White arrows indicate heterotopic cells.
(E and F) Dotted lines indicate heterotopic cells.
Exact binomial test; *p < 0.05. n = 4–6 different organoids per condition from 2 separate batches. Scale bar represents 30 mm.
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adherent junction belt along the ventricular surface, staining
strongly for b-catenin, phalloidin, and PALS1. This structure
was significantly disrupted in organoids overexpressing
PLEKHG6_4, with its constituent proteins more diffusely
dispersed (Figures 3C, 3D, and S5). The heterotopic neurons
clustering at the ventricular surface 7 dpe formed PH-like nod-
ules composed of neural progenitors (marked by SOX2) and
NeuN+ neurons (Figures 3E and 3F). Thus, modulation of
PLEKHG6_4 activity within human cerebral organoids demon-
strates a role for this factor in neurogenesis and reproduces
features of PH.
Forced PLEKHG6_4 Expression within Apical
Progenitors of the Developing Mouse Cortex Promotes
Non-cell Autonomous Expansion of Basal Progenitors
Given that PLEKHG6_4 represents a newly evolved feature of
the primate coding genome, we next assessed the effects of
forced expression of this isoform during neurogenesis. To
this end, we overexpressed this isoform in the developing
mouse cortex by in utero electroporation on embryonic day
13 (E13). Analysis 3 dpe (E16) demonstrated that forced
expression of PLEKHG6_4 decreased the proportion of GFP+
cells in the VZ and increased their numbers in the inner cortical
plate (CP1) relative to vector-only control cortices (Figures 4A
and 4B; p < 0.05). The proportion of GFP+ cells expressing
Pax6 in cortices expressing PLEKHG6_4 was reduced relative
to controls (Figures 4C and 4D). However, a significant 4-fold
expansion of basally located (Tbr2+) progenitors relative to
controls was observed after PLEKHG6_4 forced expression
(Figures 4E and 4G). We were surprised to find that
these basal progenitors were not GFP+ (Figures 4E and 4F),
indicating that, as also observed in human cerebral organoids,
a non-cell autonomous mechanism underlies this obser-
vation. Increased numbers of Tbr1+GFP+ neuronal cells were
also observed within developing cortices overexpressing
PLEKHG6_4 (Figures 4H and 4I), although this observation is
unlikely to be due to a direct effect, as PLEKHG6_4 overex-
pression in primary mouse cortices isolated at E13 and
cultured in vitro did not significantly increase the number of
neurons (b-III tubulin+), even after 5 days of differentiation
(data not shown). Similar to the organoid data, we detected
a disruption in the neuroepithelial lining within the electropo-
rated region (Figure 4J). Developing cortices electroporated
with PLEKHG6_4 expressing constructs also induce radial glial
cells to lose their radial morphology (Figure S6). These data
show that forced expression of PLEKHG6_4 in apical progen-
itors enhances the production of neurons and basal progenitor
production, the latter effect most likely through non-cell auton-
omous mechanisms.
Plekhg6 Is a Regulator of Neurogenesis and Neuronal
Migration in the Developing Mouse Brain
To better understand the mechanism leading to the defects
noted after modulation of PLEKHG6_4, we next evaluated
the phenotypic effects induced after knockdown of Plekhg6
in developing mouse cortices. To explore whether reduced
Plekhg6 levels also modulate neurogenesis, as they did in
the organoid model, we introduced a bi-cistronic vector ex-2734 Cell Reports 25, 2729–2741, December 4, 2018pressing GFP and validated microRNAs (miRNAs) directed
against Plekhg6 (Figures S7A–S7C) into the ventricular neuro-
epithelium of E13 embryos using in utero electroporation. As
for PLEKHG6_4 knockdown in organoids (and consistent
with the RhoA knockdown phenotype observed previously
[Cappello et al., 2012]), Plekhg6 knockdown induced changes
in the cellular distribution of GFP+ cells 3 dpe (E16) with an
increased fraction of GFP+ in the outer cortical plate (CP2)
relative to vector-only control cortices (Figures 5C and 5D;
p < 0.01, Figures S7A and S7C). In addition, we observed an
overmigration of neurons that breached the basement mem-
brane in five of the seven developing cortices subject to
Plekhg6 knockdown (Figure 6A). A similar effect was observed
after acute knockdown of RhoA (Cappello et al., 2012). Both
GFP+Pax6+ apical and GFP+Tbr2+ basal progenitors were
correspondingly depleted in miRNA-treated cortices relative
to the vector-only control (Figures 5E, 5G, 5I, and 5K). Mitoti-
cally active phosphorylated histone H3 (pH3+) cells positive for
GFP were also depleted 3 dpe (Figures 5F and 5J), while an
increase in the number of GFP cells positive for the early
neuronal marker Tbr1 was observed (Figures 5H and 5L).
These differences were not evident at an earlier time point
(1 dpe; Figures 5E–5L), despite a significant increase in
GFP+ cells expressing the miRNA within the upper cortical
plate (Figures 5A and 5B). These observations were not ex-
plained by changes in cell death as ascertained by the mea-
surement of activated caspase 3 (Figures S7D and S7E).
These data support a role for Plekhg6 in influencing both neu-
roprogenitor differentiation and neuronal migration.
Knockdown of Plekhg6 Mediates Changes in Neuronal
Migration via RhoA that Can Be Rescued by Human
PLEKHG6_4
To directly test whether modulation of RhoA activity can explain
the redistribution of neurons after knockdown of Plekhg6, we co-
electroporated a constitutively activated (‘‘fast cycling’’)
mutant of RhoA with the miRNA against Plekhg6 (Figures 6B
and 6C). This active form of RhoA rescued the neuronal mispo-
sitioning that was observed after Plekhg6 knockdown (Figures
6B and 6C).
With only 6% of the protein sequence differing between
PLEKHG6_1 and PLEKHG6_4 and no homology to known signal
peptides within the N terminus encoded by the unique first exon
of PLEKHG6_4, we further hypothesized that both isoforms have
the same RhoA catalytic function. Consistent with this scenario,
overexpression of human PLEKHG6_4 within E13 mouse
cortices rescued the altered neuronal distribution observed after
knockdown of Plekhg6 (Figures 6D and 6E). Further confirming
functional equivalence between PLEKHG6_4 and Plekhg6, a
RhoA/Rho kinase-based cell transfection assay demonstrated
comparable RhoGTPase activity between PLEKHG6_1 and
PLEKHG6_4 and a truncated PLEKHG6 isoform (PLEKHG6_744)
containing only the sequence in common between these two
versions (Figures 6F–6H). These data indicate that the different
N termini of each PLEKHG6 isoform do not influence its catalytic
function as a modulator of RhoA activity and suggest that it is the
differential expression patterns of these two isoforms (Figures S2
and S3) that distinguish them from each other.
Figure 4. PLEKHG6_4 Overexpression Disrupts VZ Integrity and Induces Basal Progenitor Cell Expansion in the Developing Mouse Cortex
(A) Coronal micrograph sections of E16 mouse cerebral cortices electroporated at E13 with GFP-empty vector control or human PLEKHG6 isoform 4
(PLEKHG6_4) and analyzed 3 dpe.
(B) Quantification of the distribution of GFP-expressing (GFP+) cells transfected with the various constructs in (A).
(C–I) Coronal micrograph sections of the cerebral cortex electroporated with GFP-empty vector control orPLEKHG6_4 at E13with immunostaining at E16 (3 dpe)
for Pax6 (C), Tbr2 (E), or Tbr1 (H). (D, F, G, and I) Electroporated GFP+ cells co-stained for their respective markers were counted over a representative cross-
sectional area of the cerebral cortex and presented graphically (means ± SEMs). (H) White arrowheads indicate cells staining for the indicated markers and GFP.
(J) Coronal micrograph sections of the cerebral cortex electroporated with GFP-empty vector control or PLEKHG6_4 at E13 with immunostaining at E16 (3 dpe)
for b-catenin. Red and yellow arrowheads indicate the disposition of b-catenin at the electroporated and adjacent non-electroporated ventricular surfaces,
respectively.
For (A), the cortex was subdivided into five equally thick bins approximately corresponding to VZ (bin 1), SVZ (bin 2), IZ (bin 3), and CP (bins 4 and 5). IZ,
intermediate zone; SVZ, subventricular zone. Four to six embryos were analyzed for each condition. n, total number of GFP+ cells counted per condition. Mann-
Whitney U test; *p < 0.05; ns, not significant. Scale bar represents 100 mM (A), (C), (E), (H), and (J); 50 mm (c’), (c’’), (e’), (e’’), (h’), and (h’’).DISCUSSION
The Emerging Role of bRG Dysfunction in PH and
Neurodevelopmental Disease
This study has outlined a significant link between genes with de
novo variants detected in patients with PH and the transcrip-
tional networks present in human basal progenitor cells, specif-
ically bRG. The paucity of de novo variants in genes correlating
with apical progenitor cell fate suggests that it is the functional
impairment of the basal progenitor population that is importantin the pathogenesis of at least some cases of PH. Dysfunction
of bRG may also be of broad significance for the pathogenesis
of many neurodevelopmental disorders. For example, examina-
tion of a cerebral organoid model for classical lissencephaly, a
structural malformation of cortical development characterized
by the absence of folds (i.e., gyri and sulci), highlighted delayed
mitosis specifically in bRG as one of the critical cellular defects
leading to this condition (Bershteyn et al., 2017). More widely,
an overrepresentation of variants in patients with autism spec-
trum disorders (ASDs) was also observed in loci demonstratingCell Reports 25, 2729–2741, December 4, 2018 2735
Figure 5. Plekhg6 Knockdown Disrupts Neuroprogenitor Differentiation and Neuronal Migration in the Developing Mouse Cortex
(A–D) Coronal micrograph sections of E14 (A) and E16 (C) mouse cerebral cortices electroporated at E13 with GFP-empty vector control or Plekhg6 targeting
miRNAs (miPlekhg6_1). Quantification of the distribution of GFP-expression (GFP+) cells transfected with GFP-empty vector alone or Plekhg6miRNAs 1 dpe (B)
and 3 dpe (D) (means ± SEMs).
(E–H) Coronal micrograph sections of the cerebral cortex electroporated with GFP-empty vector control or Plekhg6 miRNAs (miPlekhg6_1) at E13 with immu-
nostaining at E14 (1 dpe) or E16 (3 dpe) for Pax6 (E), pH3 (F), Tbr2 (G), or Tbr1 (H).
(I–L) Electroporated GFP+ cells co-stained for their respective markers were counted over a representative cross-sectional area of the cerebral cortex and
presented graphically (means ± SEMs).
White arrowheads indicate cells staining for the indicated markers and expressing GFP. For (A) and (C), the cortex was subdivided into five equally thick bins
approximately corresponding to VZ (bin 1), SVZ (bin 2), IZ (bin 3), and CP (bins 4 and 5). Five and seven embryos were analyzed for the 1 and 3 dpe cortices,
respectively. n, total number of GFP+ cells counted per condition. Mann-WhitneyU test; *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant. Scale bar represents
(A) 50 mm; (C) 100 mm; (E)–(G) 20 mm; and (F) and (H) 100 mm.accelerated divergence between humans and other species
(called human accelerated regions) (Doan et al., 2016). Such as-
sociations support the suggestion that an evolutionary trade-off
has occurred between recent primate brain complexification and
a susceptibility of humans to the development of neurodevelop-
mental and neuropsychiatric conditions.
Dysregulation of PLEKHG6 Isoform 4 Regulates
Neurogenesis and Neuronal Migration via RhoA
Extending the hypothesis that variants in genes that have
recently acquired functions in the brain may contribute to the for-
mation of PH, we identified two variants in ABAT and PLEKHG6
as candidates for further functional validation. Focusing on
PLEKHG6, a role for a primate-specific isoform in regulating neu-
rogenesis and neuron positioning within the developing cortex2736 Cell Reports 25, 2729–2741, December 4, 2018was identified. PLEKHG6 activates the small GTPase RhoA
(Asiedu et al., 2009), a known modulator of neuronal migration,
whose conditional depletion within the developing mouse fore-
brain is associated with heterotopically positioned neurons
along the ventricular margin (Cappello et al., 2012). In addition
to variants in PLEKHG6 being under intense purifying selection,
these data place this gene in a cellular context, the dysfunction of
which has been previously implicated in the generation of this
disease phenotype. Patients with deleterious variants in this
gene (or its differential cis-regulatory elements) will further
consolidate this proposed mechanism. In testing this hypothe-
sis, we identified multiple parallels between the consequences
of misregulation of PLEKHG6 with those that are observed after
the modulation of RhoA activity (Cappello et al., 2012). First, in-
creases in both PLEKHG6 and RhoA expression (Cappello
Figure 6. Plekhg6 Regulates RhoA to Facilitate Neuronal Migration in the Developing Mouse Cortex
(A) Coronal micrograph sections of E16mouse cerebral cortices electroporated with GFP-empty vector control or Plekhg6miRNAs (miPlekhg6_1) and stained for
laminin. White arrowheads indicate the overmigration phenotype evident at the pial surface of the cortex.
(B) Coronal micrograph sections of E16mouse cerebral cortices electroporated with GFP-empty vector control, Plekhg6miRNAs (miPlekhg6_1), or miPlekhg6_1,
together with a construct encoding a fast-cycling form of RhoA.
(C) Quantification of the distribution of GFP-expressing (GFP+) cells transfected with the various constructs in (B).
(D) Coronal micrograph sections of E16 mouse cerebral cortices electroporated at E13 with GFP-empty vector control, Plekhg6 miRNA (miPlekhg6_1), or
miPlekhg6_1, together with the miRNA-resistant human PLEKHG6 isoform 4 (PLEKHG6_4).
(E) Quantification of the distribution of GFP-expressing (GFP+) cells transfected with the various constructs in (D).
(F) Domain structure of PLEKHG6_1, truncated PLEKHG6 (PLEKHG6_744), and PLEKHG6_4. Red, common sequence; gray, unique sequences across the two
isoforms.
(G) Immunoblot showing Rho-guanine nucleotide exchange factor (GEF) activity of myc-tagged PLEKHG6 isoform 1 (PLEKHG6_iso1), truncated PLEKHG6
(PLEKHG6_744), and PLEKHG6 isoform 4 (PLEKHG6_iso4), as determined by dephosphorylation of myosin phosphatase target protein 1 (MYPT1-pT853). The
arrowhead denotes MYPT1.
(H) Quantifications representing three biological replicates of (G) summarizing the proportion of phosphorylatedMYPT1 at residue 853 relative to total MYPT1 and
normalized against the loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in HEK293 cells.
For (B) and (D), the cortex was subdivided into five equally thick bins approximately corresponding to VZ (bin 1), SVZ (bin 2), IZ (bin 3), and CP (bins 4 and 5). Five
embryos were analyzed for each condition. n, total number of GFP+ cells counted per condition. One-way ANOVA; *p < 0.05; **p < 0.01; ns, not significant, with
reference to cells in CP2. Scale bar represents 100 mm.
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et al., 2012) within the developing mouse cortex decrease the
number of neurons at the CP2. Second, knockdown of either
Plekhg6 or RhoA within the developing mouse cortex leads to
enhanced neuronal migration and even cellular overmigration
beyond the cortical plate, forming heterotopic clusters of neu-
rons at the pial surface. Alterations in the radial glial scaffold
are also observed after overexpression of RhoA or PLEKHG6_4.
RhoA rescued the altered neuronal distribution induced by
Plekhg6 knockdown, with our studies also indicating that the pri-
mate-specific version of the PLEKHG6_4 gene functionally com-
pensates for a reduction in Plekhg6_1, and that both isoforms
exhibit similar Rho GTPase-activating potential.
Several lines of evidence indicate that RhoA could represent a
major signaling mediator facilitating networks associated with
brain evolution. Recently, studies examining genetic factors
contributing to human cerebral cortex complexification using
comparative mouse and human bRG transcriptomic profiling un-
covered a novel human-specific RhoA regulator, ARHGAP11B
and a further four Rho regulators whose expression was en-
riched in bRG relative to their apical counterparts (Florio et al.,
2015). RhoA is a key determinant for bRG delamination and
OSVZ formation through activation of the Rho effector ROCK
and non-muscle myosin II (Ostrem et al., 2014). PLEKHG6 also
directly binds and regulates non-muscle myosin II activity via
RhoA (Wu et al., 2006). Results from the Rho assay described
here also show that PLEKHG6 is a regulator of the RhoA-
ROCK target protein myosin phosphatase target subunit
(MYPT-1), a known modulator of non-muscle myosin II activity
(Watanabe et al., 2007).
Although both PLEKHG6_1 and PLEKHG6_4 were identified
as having the same RhoA catalytic activity, these isoforms differ
in their spatial expression patterns (Hawrylycz et al., 2012).
Changes in temporal and spatial regulation of RhoA have been
well documented in several developmental contexts (Cappello
et al., 2012; Herzog et al., 2011; Katayama et al., 2011). For
example, conditional depletion of RhoA in the spinal cord or
midbrain of developing mouse embryos affects the maintenance
of adherens junctions but induces hypoproliferation (in spinal
cord) and hyperproliferation (in midbrain) of neural progenitor
cells in each tissue (Katayama et al., 2011; Herzog et al.,
2011). Although alternative promoter use and splicing are ubiqui-
tousmechanisms of gene regulation inmulticellular organisms to
create transcriptional diversity, their functional impact on evolu-
tionary expansion of the cerebral cortex and, in particular, basal
progenitor function is only beginning to emerge (Pollen et al.,
2015, Johnson et al., 2015).
PLEKHG6 Influences VZ Integrity
Forced expression of PLEKHG6_4 within the developing mouse
forebrain disrupted the integrity of the ventricular surface, a
mechanism that has an established precedent in the pathogen-
esis of PH (Sheen et al., 2001; Ferland et al., 2009; Carabalona
et al., 2012). Recently, a role for adhesion junction belt downre-
gulation at the VZ surface during basal progenitor delamination
(Tavano et al., 2018) was shown to be facilitated by Plekha7, a
paralog of Plekhg6, which also exhibits differential isoform
expression. Furthermore, non-cell autonomous basal progenitor
expansion was also recently reported upon knockdown of the2738 Cell Reports 25, 2729–2741, December 4, 2018chromatin remodeling factor BAF155 (Narayanan et al., 2018).
Thus, although the exact underlying mechanism resulting in
basal progenitor expansion after PLEKHG6_4 overexpression
has yet to be fully elucidated, a wider role for this family of pro-
teins and the non-cell autonomous features associated with
such events in cortical neurogenesis may be emerging.
Non-cell autonomous mechanisms are increasingly being re-
ported in the context of cortical malformations as experimental
model systems emerge that are capable of exploring these
functions. For example, in Miller-Dieker syndrome (a severe
form of lissencephaly), a recent organoid model identified im-
pairments to apical polarity machinery formation that then
disrupt cell-cell N-cadherin/b-catenin signaling within the VZ
niche, with resultant defects in cell fate control exerted in a
non-cell autonomous fashion (Iefremova et al., 2017). Such
changes were also associated with disrupted ventricular
surface integrity and a switch from symmetric to asymmetric
divisions of aRG that increased the proportion of basal interme-
diate progenitors, a phenotype comparable to that outlined in
the present study. Furthermore, a recent report showed that
ASPM (a gene whose dysregulation is linked to microcephaly)
can regulate aRG cell affinity to the ventricular surface, with
contingent effects on the expansion of basal progenitors
(bRG and basal intermediate progenitors) (Johnson et al.,
2018). This growing body of evidence links ventricular surface
integrity and apical cell dynamics with neurodevelopmental dis-
ease phenotypes and cortical complexification.
Since bRG cells are proposed to represent the cellular sub-
strate for recent primate neocortical expansion (Fietz et al.,
2010; Hansen et al., 2010), a susceptibility to develop PH could
be conferred bymutations in recently evolved genomic elements
regulating this cell type. The biallelic loss of function of a primate-
specificPLEKHG6 isoform leading to the disruption of neurogen-
esis in pathways already linked to cellular heterotopia, although
present in a single case, could also be illustrative of a wider
theme of variants in recently evolved genomic elements leading
to developmental disorders (Doan et al., 2016). Such a result has
significant implications for the functional study of this and other
neurodevelopmental disorders and could explain why mice
models frequently do not recapitulate phenotypes relating to
basal progenitor cellular dysfunction (Feng et al., 2006; Hart
et al., 2006; Corbo et al., 2002). We anticipate that evolutionarily
dynamic non-coding sequences (Vermunt et al., 2016) will har-
bor similar genomic innovations that can be linked to neurodeve-
lopmental disease in humans. Where the genetic substrate for
such functions is not present in the genome of mammals typi-
cally used to model neurodevelopmental conditions (e.g.,
mice), studies of individuals with neurodevelopmental disorders
such as PH can direct attention to key regions of the genome that
may contribute to cortical complexification in humans.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
PH Trios
We utilized 65 trios (affected child and both parents) characterized and contributed by us in a previous study (Heinzen et al., 2018).
Study participants can be identified here through the prefix ‘pvhnz’ in the cohort identifier table, were data describing the sex of these
participants can also be identified. All study participants were ascertained by physician referral, presumed sporadic disease based
on patient and family interview, and consented to participate under the University of Otago consent protocol. Ethical approval was
obtained from the Southern regional Ethics Committee O03/016 and the NewZealand Ethics CommitteeMEC08/08/094. Specifically
this ethical approval does not allow for the general sharing of individual exome sequences on confidentiality grounds.
iPSC generation and human organoids
Male human iPSCs were reprogrammed from human newborn foreskin fibroblasts (CRL-2522, ATCC). iPSCs were authenticated af-
ter reprogramming by karyotyping. The use of iPSCs to generate cerebral organoids was approved by the Ethics Commission of LMU
(Ludwig-Maximilians-Universita¨t M€unchen), with the association number 115-16. iPSCs and human organoids were cultured at 37C,
5% CO2 and ambient oxygen level on Geltrex coated plates in mTeSR1 medium with daily medium change. Electroporations were
performed in cerebral organoids at 42 days stages after the initial plating of the cells and fixed 4 or 7 days post electroporation.
Mice
All the animals used in this work were kept in the animal facility of the Helmholtz Zentrum M€unchen. All the experimental procedures
were performed in accordance with German and European Union guidelines. Animals were maintained on a 12 hour light-dark cycle.
The day of vaginal plug was considered as embryonic day 0 (E0). In this study the C57BL/6Jmouse linewas used. All animals used for
in utero electroporation were female between 4 – 6 months of age.
METHOD DETAILS
Whole-exome sequencing
Whole-exome sequencing was carried out by Otogenetics Corporation (Norcross, GA, USA). Sequencing libraries were prepared
from genomic DNA extracted from leukocytes of parents and patients using Wizard Genomic DNA Purification Kit (Promega,
Cat. A1620) following the manufacturer’s instructions. Library DNA was exome enriched using the Agilent SureSelect Human All
Exon V4+UTRs capture kit, and sequenced on an Illumina Hiseq2000, Illumina, San Diego, CA using 100 bp paired-end reads. Align-
ment of the sequenced DNA fragments to the Ensembl Genome Browser human genome assembly (GRCh37) was carried out using
the Burrows-Wheeler Aligner (MEM algorithm) v.0.7.12. After alignments were produced for each individual separately, the data was
locally realigned around indels followed by base quality score recalibration using Genome Analysis Tool Kit (GATK) Best Practices
IndelRealigner (version 3.4-46; Broad Institute). Duplicate reads were removed using PICARD (version 1.140; Broad Institute). Indi-
vidual variant calling was undertaken using the GATK HaplotypeCaller, followed bymultisample genotyping and variant quality score
recalibration. Variant call format file (VCF) gene context annotation was added using SnpEff v.4.1L. Allele frequencies were obtained
from 1000 Genomes Project phase 1, NHLBI GO Exome Sequencing Project ESP6500 and the Exome Aggregation Consortium
(ExAC) via the GATK VariantAnnotator.
Whole-exome sequencing variant calling
All alignments with loci bearing putative de novomutations were extracted from themultisample VCF using GATK SelectVariants and
SnpSift v.4.1L (SnpEff) that met the following criteria: (1) the read depth should beR 8 within the patient; (2) at least 20% of the reads
should carry the alternate allele; (3) < 5% of the reads in either parent should carry the alternative allele; (4) at least two alleles must be
observed in the proband; (5) the genotype quality (GQ) score for the offspring’s alternate allele should be 99; (6) the normalized,
phred-scaled genotype likelihood (PL) scores in both parents for the three possible genotypes 0/0, 0/1 and 1/1, where 0 is the refer-
ence allele and 1 is the alternative allele, should be > 0, > 20 and > 20, respectively. Candidate de novomutations were also absent
from population controls, including a set of 107 internally sequenced controls and the 60,706 individuals whose single nucleotide
variant data are reported in ExAC. All candidate de novomutations were Sanger sequenced using the relevant proband and parents
for confirmation. Using our filtering approach across the entire cohort of 65 individuals we identified 177 potential de novomutations,
of which, 50 were independently validated by Sanger sequencing (28% validation rate). Of the 127 variants that did not validate, 21
were false negatives in parents while 106 were false positives in the probands, implying this analysis overall had high sensitivity to
detect de novo variants at the cost of lower specificity.
Loci bearing putative recessive variants were extracted from the VCF that met the following criteria: (1) the read depth should beR
8 or 20 for compound heterozygous or homozygous recessive genotype calls in the patient, respectively; (2) at least 20% and 90%of
the reads in the patient should carry the alternate allele for candidate compound heterozygous and homozygous genotypes, respec-
tively; (3) in the parents, at least one individual requires a read depthR 30; (4) candidate recessive variants should not be present ine3 Cell Reports 25, 2729–2741.e1–e6, December 4, 2018
population controls, including a set of 107 internally sequenced controls and the 60,706 individuals whose single nucleotide variant
data are reported in ExAC. All candidate recessive variants were Sanger sequenced using the relevant proband and parents for
confirmation.
Burden analysis
Modeling apical and basal progenitor gene mutation rates
To assess whether there is an excess of de novo variants identified specifically within gene sets that define apical and basal radial glia
(aRG and bRG, respectively) we used loci that define these functional classes for each cell type as outlined by others (Pollen
et al., 2015). The expected rate for each gene set was calculated by establishing the gene-specific mutation rates [presented as
log10(prob)] provided in (Samocha et al., 2014). These gene-specific mutation rates are based primarily on estimated triplet-specific
mutations rates, thus taking into account sequence context and gene size, by way of validation, they accurately predict the amount of
synonymous variation seen in coding sequences. Thus, for genes defining a bRG transcriptomic signature the expected number of de
novo variants was 0.26 for a denominator of 67 genes (defined in (Pollen et al., 2015)) in a cohort of 65 patients using the approach
devised by (Samocha et al., 2014). Similarly, for the aRG transcriptomic signature the expected number of de novo variants was 0.13
for a denominator of 33 genes (defined in (Pollen et al., 2015)) in a cohort of 65 patients using the approach of (Samocha et al., 2014).
Assessing for gene set enrichment
For determining overlap with de novomutations, functional gene classes were defined as follows. ‘FMRP’ are genes encoding tran-
scripts that bind to FMRP (Darnell et al., 2011). ‘Chromatin’ indicates chromatin modifiers as defined by GO (http://www.
geneontology.org/). ‘PSD’ is a set of genes encoding proteins that have been identified in postsynaptic densities (Baye´s et al.,
2011). ‘Mendelian’ represent positionally identified human disease genes (Feldman et al., 2008), and ‘Essential’ genes are human
orthologs of mouse genes associated with lethality in the Mouse Genome Database (Blake et al., 2011). ‘Embryonic’ genes are those
expressed in post-mortem human embryonic brains (Voineagu et al., 2011), derived from downloaded expression data (Kang et al.,
2011). All gene lists have also been used elsewhere (Iossifov et al., 2014). Tests assessing excess were carried out using the Exact
binomial test (two-tailed) with the expected rate for each gene set being calculated using the approach described above and of
(Samocha et al., 2014).
Analysis of PLEKHG6 evolutionary conservation
Ensembl, NCBI and USCS genome bioinformatics data were assessed for the first exon coding sequence orthologs of PLEKHG6
isoform 1 and 4 across species. The evolutionary tree was generated using iTOL (Letunic and Bork, 2011).
Reprogramming of human fibroblasts to induced pluripotent stem cells (iPSCs)
Male human iPSCs were reprogrammed from human newborn foreskin fibroblasts (CRL-2522, ATCC). 2.5x105 NuFF3-RQ IRR hu-
man newborn foreskin feeder fibroblasts (GSC-3404, GlobalStem) were seeded per well of a 6-well tissue culture dish with advanced
MEM (12491015, Thermo Fisher Scientific) supplemented with 5%HyClone Fetal Bovine Serum (SV30160.03HI, GE Healthcare), 1%
MEM NEAA and GlutaMAX (11140050; 35050061 Thermo Fisher Scientific). On day 1, 70%–80% confluent CRL-2522 fibroblasts
were dissociated using 0.25% Trypsin-EDTA (25200056, Life Technologies), counted and seeded on the NuFF3-RQ cells at two
different densities: 2x104 cells/well and 4x104 cells/well. On day 2, the medium was changed to Pluriton Reprogramming Medium
(00-0070, Stemgent) supplemented with 500 ng/ml carrier-free B18R Recombinant Protein (03-0017, Stemgent). On days 3-18, a
cocktail of modifiedmRNAs (mmRNAs) containing OCT4, SOX2, LIN28, C-MYC, and KLFmmRNAs at a 3:1:1:1:1 stoichiometric ratio
was transfected daily. For that purpose, the mmRNAs were mixed in a total volume of 105ml and were combined with a mix of 92ml
Opti-MEM I Reduced Serum Medium and 13ml Lipofectamine RNAiMAX Transfection Reagent (31985062, Thermo Fisher Scientific)
after separate incubation at RT for 15 min. Cells were transfected for 4hrs, washed and fresh reprogramming medium supplemented
with B18R was added to the cultures. The mmRNAs with the following modifications: 5-Methyl CTP, a 150 nt poly-A tail, ARCA cap
and Pseudo-UTP were obtained from the RNA CORE unit of the Houston Methodist Hospital. 5 days after the first transfection, the
firstmorphological changeswere noticed, while the first induced pluripotent stem cell (iPSC) colonies appeared by day 12-15. On day
16, the medium was changed to STEMPRO hESC SFM (A1000701, Thermo Fisher Scientific) for five days. Harvesting of the iPSC
colonies was performed after 40min incubation at 37C with 2mg/ml Collagenase Type IV (17104019, Thermo Fisher Scientific) so-
lution in DMEM/F12 (31331093, Thermo Fisher Scientific). The iPSCs were plated on g-irradiated mouse embryonic fibroblasts
(MEFs) and grown in STEMPRO hESC SFM for 10 additional passages. After that the iPSCs were further cultured in a feeder-free
culture system, using mTeSR1 (05850, StemCell Technologies) on plates coated with LDEV-Free Geltrex (A1413302, Thermo Fisher
Scientific). iPSCs were authenticated after reprogramming by karyotyping.
iPSC culture
IPSCs were cultured at 37C, 5% CO2 and ambient oxygen level on Geltrex coated plates in mTeSR1 medium with daily medium
change. For passaging, iPSC colonies were incubated with StemPro Accutase Cell Dissociation Reagent (A1110501, Life Technol-
ogies) diluted 1:4 in PBS for 4 minutes. Pieces of colonies were washed off with DMEM/F12, centrifuged for 5 min. at 300 x g and
resuspended in mTeSR1 supplemented with 10 mM Rock inhibitor Y-27632(2HCl) (72304, StemCell Technologies) for the first day.
Cerebral organoid generation
Cerebral organoids were generated as previously described (Lancaster and Knoblich, 2014). Briefly iPSCswere dissociated in to sin-
gle cells using StemPro Accutase Cell Dissociation Reagent (A1110501, Life Technologies) and plated in the concentration of 9000
single iPSCs/well into low attachment 96-well tissue culture plates in hES medium (DMEM/F12GlutaMAX supplemented with 20%Cell Reports 25, 2729–2741.e1–e6, December 4, 2018 e4
Knockout Serum Replacement, 3% ES grade FBS, 1% Non-essential amino acids, 0.1mM 2-mercaptoethanol, 4ng/ml bFGF and
50 mM Rock inhibitor Y27632) for 6 days in order to form embryoid bodies (EBs). Rock inhibitor Y27632 and bFGF were removed
on the 4thday. On day 6 EBs were transferred into low attachment 24-well plates in NIM medium (DMEM/F12GlutaMAX supple-
mented with 1:100 N2 supplement, 1% Non-essential amino acids and 5 mg/ml Heparin) and cultured for additional 6 days. On
day 12 EBs were embedded in Matrigel (Corning, 354234) drops and then they were transfer in 10cm tissue culture plates in
NDM minus A medium (DMEM/F12GlutaMAX and Neurobasal in ratio 1:1 supplemented with 1:100 N2 supplement 1:100 B27
without Vitamin A, 0.5% Non-essential amino acids, insulin 2.5 mg/ml, 1:100 Antibiotic-Antimycotic and 50mM 2-mercaptoethanol)
in order to form organoids. 4 days after Matrigel embedding cerebral organoids were transfer into an orbital shaker and cultured until
electroporation in NDM plus A medium (DMEM/F12GlutaMAX and Neurobasal in ratio 1:1 supplemented with 1:100 N2 supplement
1:100 B27 with Vitamin A, 0.5% Non-essential amino acids, insulin 2.5 mg/ml, 1:100 Antibiotic-Antimycotic and 50 mM 2-mercaptoe-
thanol). During the whole period of cerebral organoid generation, cells were kept at 37C, 5% CO2 and ambient oxygen level with
medium changes every other day. After transferring the cerebral organoids onto the shaker medium was changed twice per week.
Assessing PLEKHG6_4 knockdown efficiencies
Efficiency of miRNA knockdown targeted by PLEKHG6_4 (miPLEKHG_4) was determined by transient co-transfection with a
PLEKHG6_4 expression plasmid (pcDNA3.1V5/His-PLEKHG6_4), and data expressed as relative PLEKHG6_4 expression. Specif-
ically, HEK293FT cells were transfected with miPLEKHG_4 (400ng and 800ng), and a mock transfected control followed by growth
for 22 hours before secondary transfection with pcDNA3.1V5/His-PLEKHG6_4 (400ng). After a further 22 hours of growth total cell
lysates were prepared and subjected to western blot analysis using anti-V5 antibody (mouse, Thermo Fisher Scientific Cat # R96025,
1:2500) to detect tagged PLEKHG6_4 expression. Relative expression of PLEKHG6_4 was calculated for eachmiPLEKHG_4 sample
as the ratio of PLEKHG6_4 expression to mock transfected control. Data presented as mean (±SEM). Mann-Whitney U test;
* p < 0.05.
Electroporation of cerebral organoids
Cerebral organoids were kept in antibiotics-free conditions prior to electroporation. Electroporations were performed in cerebral or-
ganoids at 42 days stages after the initial plating of the cells and fixed 4 or 7 days post electroporation. During the electroporation
cerebral organoids were placed in an electroporation chamber (Harvard Apparatus, Holliston, MA, USA) under a stereoscope and
using a glass microcapillary 1-2 mL of plasmid DNAs at final concentration of 1 mg/ml was injected together with Fast Green
(0.1%, Sigma) into different ventricles of the organoids. Cerebral organoids were subsequently electroporated with 5 pulses applied
at 80V for 50ms each at intervals of 500ms using the Electroportator ECM830 (Harvard Apparatus). Following electroporation cere-
bral organoids were kept for additional 24 hours in antibiotics-free media, and then changed into the normal media until fixation.
Cerebral organoids were fixed using 4% PFA for 1h at 4C, cryopreserved with 30% sucrose and then stored in 20C. For immu-
nofluorescence, 16 mm cryosections were prepared. For each experiment, many independent ventricles per organoid from 4-6
different organoids per condition were analyzed. pCAGGS was used as the control plasmid. Human PLEKHG6 isoform 4 targeting
miRNA-expressing constructs [miPLEKHG6_4 (50- ccacaggcaaatgaaggaatg 30)] were cloned into the pcDNA6.2-GW/miR vector
(Blockit, Invitrogen) according to themanufacturer’s instructions. Plasmidswere subsequently recombined into pCAGGSdestination
vector.
Immunofluorescence of human cerebral organoid cells
Tissues were processed as per mouse cortical tissue. Before sections were blocked they were boiled in calcium chloride (1% solu-
tion) for 5minutes. Sections were blocked and permeabilized in 0.25%Triton X-100, 4% normal donkey serum in PBS. Sections were
then incubated with primary antibodies in 0.1% Triton X-100, 4% normal donkey serum at the following dilutions: PCNA
(mouse IgG2a, DAKO, Cat. # M0879, 1:40), MAP2 (mouse IgG1, Sigma, Cat. # M4403, 1:300), PLEKHG6 isoform one and isoform
four (rabbit, MIMOTOPES, 1:1000, each). Sections were incubated overnight at 4C. The next day slides were washed in three times
in PBS and then treated as per the manufacturer’s instructions for the Thyramid kit (ThermoFisher, Cat. # T20922) to amplify the
detection of PLEKHG6 isoforms one and four, separately. The appropriate secondary fluorophore antibodies were used for PCNA
and MAP2 as per the manufacturer’s instructions. PLEKHG6 isoform one and four antibodies were generated, specifically, from
MIMOTOPES (Clayton, Australia). The peptides used to establish immunogenicity were N-MKAFGPPHEGPLQGL-C and
N-MGCRLHAPGEKAAH-C for isoform one and four, respectively. Both peptides were conjugated to KLH through Cys coupling at
their C-termini. For all the other immunostainings which were performed in human cerebral organoids the following protocol was
used. Sections were post-fixed with 4% PFA for 10 mins, permeabilized in 0.3% Triton X-100 and then blocked with 0.1% Tween,
3%BSA and 10%normal goat serum. Sections then incubated with primary antibodies diluted in blocking solution. GFP (chick, Aves
Lab, Cat # GFP-1020, 1:1000), Sox2 (rabbit, Cell Signaling Cat # 2748S, 1:500), b-catenin (mouse, Proteintech Cat # 610154, 1:500),
NeuN (mouse, Millipore Cat # MAB377, 1:500), Phalloidin (Alexa Fluor 488-conjugated PHALLOIDIN, Thermo Fisher Cat # A12379,
1:80), PALS1 (rabbit, Sigma Aldrich Cat # 07-708, 1:500).
Anesthesia
To perform in utero operations, mice were anaesthetised by subcutaneous injection of a solution containing: Fentanyl (0.05 mg/kg),
Midazolam (5 mg/kg) and Medetomidine (0.5 mg/kg). The anesthesia was terminated with a subcutaneous injection of a solution
composed of Buprenorphine (0.1 mg/kg), Atipamezol (1.5 mg/kg) and Flumazenil (0.5 mg/kg).e5 Cell Reports 25, 2729–2741.e1–e6, December 4, 2018
In utero electroporation
Surgery was performed on animals in accordance with the guidelines of Government of Upper Bavaria under license number 55.2-1-
54-2532-79-2016. E13 pregnant dams were anesthetized and operated on as previously described (Saito, 2006). In brief, the shaved
abdomen was opened by caesarean section in order to expose the uterine horns. These were kept wet and warm by continuous
application of pre-warmed saline. Endotoxin free vectors – diluted to 1.5 mg/mL – were mixed in Fast green (2.5 mg/mL, Sigma).
1 mL of mix was injected into the ventricle with the aid of glass capillaries (self-made with a micropipette puller). DNA was electro-
porated into the telencephalon with five pulses of 38mV for 100ms each. At the end of the entire electroporation procedure, the uter-
ine horns were repositioned into the abdominal cavity, which was then filled with pre-warmed saline. The abdominal wall was closed
by surgical sutures (Ethicon, Cat. # K832H). Anaesthesia is reversed as described above and animals were monitored appropriately.
At E14 (one day post electroporation) or E16 (three days post electroporation) operated animals were sacrificed by cervical disloca-
tion. Embryos were placed in HBSS (Hank’s Balanced Salt Solution – GIBCO, Life Technologies) supplemented with 10 mM
HEPES (GIBCO, Life Technologies). Embryos were dissected and brains fixed. pCAGGS was used as the control plasmid. Plekhg6
targeting miRNA-expressing constructs [miRNA1 (50- ctaaccagcaatctgtcacct 30), miRNA2 (50- tgcacctgaactaaccagcaa 30),
miRNA3 (50- tactgtggaaatctgggtcgt 30)] were cloned into the pcDNA6.2-GW/miR vector (Blockit, Invitrogen) according to the man-
ufacturer’s instructions. Plasmids were subsequently recombined into pCAGGS destination vector.
Immunofluorescence of mouse cortical tissue
Mouse cortical tissues were fixed in 4% paraformaldehyde for 20 min at 4C followed by washing in PBS three times 10 min. Tissues
were allowed to sink in 30% sucrose overnight and then embedded into molds (Polysciences, Cat. # 18646A-1) using Tissue-Tek
(Hartenstein, Cat. # TTEK) and frozen on dry ice. Tissue was then stored at 20C until it was cryosectioned in 20 mm sections
with a Cryostat (Leica). Sections were blocked and permeabilized in 0.25% Triton X-100, 4% normal donkey serum in PBS. Sections
were then incubated with primary antibodies in 0.1% Triton X-100, 4% normal donkey serum at the following dilutions: GFP (chick,
Aves Lab, Cat. # GFP-1020, 1:500), Pax6 (rabbit, Merck-Millipore, Cat. # AB2237, 1:500), pHistone H3 mitosis MKR (pH3) (rabbit,
Merck-Millipore, Cat. # 06-570, 1:1000), Tbr2 (rabbit, Merck-Millipore, Cat. # AB2283, 1:500), Tbr1 (rabbit, Abcam, Cat. #
ab31940, 1:500), laminin (rabbit, Abcam, Cat. # ab11575, 1:500), ac-tubulin (mouse, Sigma, Cat # T6793, 1:800 and active
caspase-3 (rabbit, Abcam, Cat. # ab32042, 1:500). Sections were incubated overnight at 4C. The next day slides were washed three
times in PBS and then treated as per the manufacturer’s instructions with the appropriate secondary fluorophore antibodies.
RhoGAP activity assay
DNA constructs expressing full-length and truncated version of human PLEKHG6 isoform 1 and 4 were generated by standard clon-
ing techniques. Expression constructs were transiently transfected into HEK293 cells with Lipofectamine 2000 (Invirogen, Cat. #
11668-019) according to the manufacturer’s instructions. Cells were lysed 20 hours post transfection in 1x tris buffered saline
(TBS), 1% (v/v) Triton X-100 and Complete Protease Inhibitor (Roche) on ice for 20 min. Cell debris was then pelleted through centri-
fugation at 13,000 rpm 4C for 10min. 20 mL of protein lysate was combined with protein loading dye (final concentration: 50 mM Tris
pH 6.8, 10% glycerol, 2% SDS, 6% 2-mercaptoethanol and 1%w/v Bromo blue) and denatured at 95C for 5 min, before being sub-
jected to SDS-PAGE. Immunoblot analysis was performed using anti-myosin phosphate target protein 1 (MYPT1; rabbit, Cell
Signaling Technology, Cat. # 2634, 1:1000), anti-MYPT1-pT853 (rabbit, Cell Signaling Technology, Cat. # 4563, 1:1000) and anti-
GAPDH (rabbit, Sigma-Aldrich, Cat. # G9545, 1:3000).
QUANTIFICATION AND STATISTICAL ANALYSIS
Analyses were performed using the R statistical sorftware in the case of the burden analyses, with all other tests analyzed in Graph-
pad Prism 7.0 software. To compare the statistical difference between two experimental groups we used an unpairedMann-Whitney
U test. For assessing the statistical difference between at least three experimental groups, Oneway-ANOVAwas used. Fisher’s exact
test was used for assessing categorical data in Table 1, Figure 3 and Table S4. Data are represented as mean ± s.e.m. In the case of
categorical data, we did not correct p values for multiple comparisons because our primary hypotheses focused on de novo variants
with all subsidiary tests not being part of the primary examination of the hypothesis. Experimental repeat numbers and statistical test
performed for each dataset are described in themain text within each respective figure legend. For each experiment, embryos fromat
least two different females were used with the total number of cells counted shown below each treatment bar in each graph of the
figure. Significance was set at p = 0.05. For in utero electroporations, all quantifications weremade in at least 5 embryos. For electro-
porations performed in cerebral organoids, several independent ventricles were analyzed from 4-6 different organoids per condition
from two independent batches.Cell Reports 25, 2729–2741.e1–e6, December 4, 2018 e6
